89 related articles for article (PubMed ID: 2942267)
1. [Problems in the determination of immunocomplexes. II. C1q binding test].
Votruba T; Rákosník P
Cesk Epidemiol Mikrobiol Imunol; 1986 Jul; 35(4):239-45. PubMed ID: 2942267
[No Abstract] [Full Text] [Related]
2. [Determination of immunocomplexes. III. A method using a solid surface for immunocomplex binding and use of C1q subcomponent of the first complement component (C1q SP)].
Votruba T; Rákosník P
Cesk Epidemiol Mikrobiol Imunol; 1988 Feb; 37(1):15-22. PubMed ID: 2967114
[No Abstract] [Full Text] [Related]
3. [Determination of immunocomplexes. I. The C1q subunit of the first complement component and using its qualification in the determination of circulating immunocomplexes].
Votruba T; Rákosník P; Vancurík J
Cesk Epidemiol Mikrobiol Imunol; 1985 Nov; 34(6):321-8. PubMed ID: 2934147
[No Abstract] [Full Text] [Related]
4. Specific proteins precipitated by polyethylene glycol during assays for circulating C1q precipitable immune complexes.
Hyun J
Am J Clin Pathol; 1983 Nov; 80(5):777-8. PubMed ID: 6605678
[No Abstract] [Full Text] [Related]
5. [Clinical significances of circulating immune complexes in connective tissue diseases--detection by C1q deviation test, precipitin reaction of C1q in gel diffusion, anti-antibody inhibition test and precipitation with polyethylene glycol].
Yasuda M
Ryumachi; 1983 Oct; 23(5):315-26. PubMed ID: 6608796
[No Abstract] [Full Text] [Related]
6. [Specificity, sensitivity and reproducibility of 2 methods of determining serum immunocomplexes (solid-phase C1q and polyethylene glycol precipitation)].
Coppo R; De Marchi M; Basolo B; Martina G; Rollino C; Boero R; Giraudo G; Rossano C; Quarello F; Piccoli G
Arch Sci Med (Torino); 1982; 139(4):381-92. PubMed ID: 6984818
[TBL] [Abstract][Full Text] [Related]
7. Detection and quantitation of circulating immune complexes by the C1q-protein A binding assay (C1q-PABA).
Glikmann G; Svehag SE
Methods Enzymol; 1981; 74 Pt C():571-88. PubMed ID: 6798369
[No Abstract] [Full Text] [Related]
8. The [125I]C1q binding assay for the detection of soluble immune complexes.
Zubler RH; Carpentier N; Lambert PH
Methods Enzymol; 1981; 74 Pt C():530-7. PubMed ID: 6976503
[No Abstract] [Full Text] [Related]
9. Ability to activate complement is not required for the detection of immune complexes by the fluid-phase C1q binding assay.
Fiocco GP; Davis JS; Burge JJ
Arthritis Rheum; 1985 Feb; 28(2):222-5. PubMed ID: 3871617
[No Abstract] [Full Text] [Related]
10. Immune complex assays and their limitations.
Kilpatrick DC; Weston J
Med Lab Sci; 1985 Apr; 42(2):178-85. PubMed ID: 2933572
[No Abstract] [Full Text] [Related]
11. Effect of EDTA on the solid phase Clq immune complex assay.
Davey MP; Korngold L
Int Arch Allergy Appl Immunol; 1982; 67(3):275-7. PubMed ID: 6800962
[No Abstract] [Full Text] [Related]
12. [Detection of circulating immune complexes by enzyme immunoassay. A basic study of C1q enzyme immunoassay and anti-C3 enzyme immunoassay using microplates].
Yokoyama K
Arerugi; 1984 Feb; 33(2):117-26. PubMed ID: 6380453
[No Abstract] [Full Text] [Related]
13. [The effect of ampicillin on the measurement of circulating immune complex by C1q solid-phase enzyme immunoassay].
Tokuyama K; Mitsuhashi M; Tajima K; Morikawa A; Tamura H
Arerugi; 1984 Jul; 33(7):418-23. PubMed ID: 6388531
[No Abstract] [Full Text] [Related]
14. [Demonstration of circulating immune complexes using a C1q-solid phase enzyme immunoassay].
Schössler W; Hiepe F; Courault K; Porstmann B; Apostoloff E
Biomed Biochim Acta; 1983; 42(7-8):1027-35. PubMed ID: 6360166
[TBL] [Abstract][Full Text] [Related]
15. [Determination of immune complex levels--with special reference to C1q and the anti-antibody method].
Kasukawa R
Rinsho Byori; 1986 Oct; Spec No 69():35-44. PubMed ID: 3543438
[No Abstract] [Full Text] [Related]
16. [Circulating immune complexes: optimization and characteristics of the C1q(I125) fixation test].
Caillot G; Lamelin JP; Hartmann DJ; Ville G
Pathol Biol (Paris); 1984 Nov; 32(9):931-7. PubMed ID: 6334270
[TBL] [Abstract][Full Text] [Related]
17. The interference of fibrinogen and heparin with the determination of circulating immune complexes in the C1q-binding assay.
Faaber P; Capel PJ; Koene RA
Clin Exp Immunol; 1981 Sep; 45(3):590-4. PubMed ID: 6978209
[TBL] [Abstract][Full Text] [Related]
18. The use of glass as solid phase in enzyme immunoassay as exemplified by the detection of circulating immune complexes.
Schössler W; Hiepe F; Montag T; Schmidt HE
Biomed Biochim Acta; 1985; 44(7-8):1247-53. PubMed ID: 3910036
[TBL] [Abstract][Full Text] [Related]
19. A method for rapid determination of IgG containing circulating immune complexes using polyethyleneglycol and radioactively labeled protein A.
Stevens WJ; Bridts C
Immunol Lett; 1981 Apr; 3(1):1-4. PubMed ID: 7024111
[TBL] [Abstract][Full Text] [Related]
20. Critical aspects of immune complex assays employing polyethylene glycol.
Cooper KM; Moore M
J Immunol Methods; 1983 Jun; 60(3):289-303. PubMed ID: 6602185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
